Use of biologic response modifiers for the management of ocular inflammatory conditions
Ocular inflammatory conditions can be challenging to manage due to their prolonged and complicated nature. While the mainstay treatment for most cases is oral or topical corticosteroids, it is very important that physicians know how other medications such as biologic response modifiers (biologics) c...
Saved in:
Main Authors: | Erick Rivera-Grana, Jay Siak, James T Rosenbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=4;spage=259;epage=263;aulast=Rivera-Grana |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologics in ocular inflammatory diseases – Experience from a tertiary referral eye care center in South India
by: Kalpana Babu, et al.
Published: (2025-02-01) -
Infectious scleritis: a review of etiologies, clinical features, and management strategies
by: Supriya Sharma, et al.
Published: (2025-02-01) -
Patient Characteristics, Diagnoses, and Management in a Combined Uveitis–Rheumatology Clinic
by: Jason Shawver, et al.
Published: (2025-01-01) -
Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
by: Mariam M. Boshra, et al.
Published: (2025-01-01) -
Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation
by: Chunbo Zhang, et al.
Published: (2025-01-01)